Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib
Juan Carlo Avalon(West Virginia University), Brijesh Patel(Maharaja Sayajirao University of Baroda), Chelby Wakefield(West Virginia University), Wei Fang, Austin King(West Virginia University), Lauren Veltri(West Virginia University), Michael T. Craig(West Virginia University), Christopher Bianco(West Virginia University), Midhun Malla(University of Alabama at Birmingham), Jacob Fuqua(West Virginia University), Sonya Inderbitzin-Brooks(West Virginia University), Seth Deskins(West Virginia University), Abraham S. Kanate(HonorHealth), Kelly Ross(West Virginia University), Tyler Miller(West Virginia University)
Cited by 19
Related Papers
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2024|333
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2020|278
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
|Journal of Clinical Oncology|2022|276